National Healthcare Corp. Form 4 Filings

NATIONAL HEALTHCARE CORP (NHC) reported that Senior Vice President and Chief Financial Officer Brian F. Kidd sold 6,813 shares of common stock on September 11, 2026 in an open-market or private transaction at $225.70 per share, leaving him with 23,183 common shares held directly. He also reports directly held options to purchase common stock with exercise prices of $53.94 (4,147 underlying shares, expiring March 8, 2028), $94.10 (4,000 shares, expiring March 5, 2029), $90.62 (9,000 shares, expiring February 24, 2030), and $157.13 (14,000 shares, expiring February 23, 2031). No Rule 10b5-1 trading plan is reported for this transaction.

NATIONAL HEALTHCARE CORP (NHC) reports that Senior VP & CIO Ben Anderson Flatt Sr. sold a total of 7 blocks of 1,000 shares of common stock each in open-market or private transactions between August 12, 2026 and August 28, 2026, at prices from $221.21 to $237.18 per share. No Rule 10b5-1 trading plan is reported for these sales. He continues to hold options to purchase National Healthcare Corp common stock, including options exercisable for 4,000 shares at $94.10 expiring March 5, 2029, 9,000 shares at $90.62 expiring February 24, 2030, and 14,000 shares at $157.13 expiring February 23, 2031.

NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford reported a sale of company common stock. On 2026-08-25 he sold 1,779 shares of common stock in an open-market or private transaction at $225.42 per share, and now directly holds 1,030 shares of NHC common stock.

NATIONAL HEALTHCARE CORP (NHC) director David R. Gifford reported an option exercise and related share withholding. On August 20, 2026, he exercised 6,479 stock options granted under the 2020 Omnibus Equity Incentive Plan at an exercise price of $171.42 per share, receiving 6,479 common shares. In a separate transaction the same day, 4,691 common shares were withheld by the company at $236.75 per share to pay the exercise price. The options were granted on May 7, 2026 and are exempt from Section 16(b) under Rule 16b-3(d).

NATIONAL HEALTHCARE CORP (NHC) reported that CEO and director Stephen Fowler Flatt sold 1,500 shares of Common Stock on 2026-08-19 at $237.08 per share in an open-market or private sale, leaving him with 65,487 directly held shares. He also continues to hold several option awards on NHC Common Stock with varying exercise prices and expirations.

NATIONAL HEALTHCARE CORP director David R. Gifford reported an option exercise on August 13, 2026. He exercised 1,021 options from a 2026 grant with an exercise price of $171.42 per share, receiving 1,021 shares of common stock. After the transactions, he directly holds 1,021 common shares and 6,479 options from this grant, which was issued under the 2020 Omnibus Equity Incentive Plan and is stated as exempt from Section 16(b) under Rule 16b-3(d).

National Healthcare Corp director HASSAN EMIL E reported an open-market sale of 5,937 shares of common stock at $200.00 per share on June 22, 2026, and now directly holds 65,595 shares.

The director also holds multiple stock option grants, each covering 7,500 underlying common shares, with exercise prices ranging from $55.75 to $171.42 and expiration dates from 2027 through 2031. These options represent ongoing equity-based compensation rather than new purchases or sales.

National Healthcare Corp’s SVP and CFO, Brian F. Kidd, reported a Form 4 showing a bona fide gift of 500 shares of common stock at $0.00 per share, leaving him with 29,996 common shares held directly.

The filing also details his outstanding stock options on common stock, including 14,000 underlying shares at $157.13 expiring on February 23, 2031, 9,000 shares at $90.62 expiring on February 24, 2030, 4,000 shares at $94.10 expiring on March 5, 2029, and 4,147 shares at $53.94 expiring on March 8, 2028.

NATIONAL HEALTHCARE CORP director Emil E. Hassan reported an open-market sale of 1,563 shares of common stock at $199.975 per share. After this transaction, he directly holds 71,532 shares. He also retains several stock option awards, each covering 7,500 underlying shares from 2022–2026 grants with exercise prices between $55.75 and $171.42 and expirations from 2027 to 2031.

National Healthcare Corp director Robert G. Adams reported routine equity movements involving company stock and options. On 2026-06-08, a trust for which he serves as trustee exercised options to acquire 4,000 shares of common stock at $69.19 per share, and that same trust made a bona fide gift of 4,000 shares at no stated price.

Separate entries list his indirect partnership holdings of 430,341 shares and show that, after these transactions, the trust holds 13,579 shares. He also continues to hold multiple stock option grants directly, each covering 7,500 underlying shares with exercise prices between $55.75 and $171.42 and expirations from 2028 to 2031. The filing reflects exercises, gifts, and existing holdings rather than open-market buying or selling.

NATIONAL HEALTHCARE CORP director Lisa Piercey reported an open‑market purchase of 949 shares of Common Stock at $184.2559 per share. Following this transaction, she holds 949 Common shares directly. The filing also lists a 2026 stock option grant covering 7,500 underlying Common shares at a $171.42 exercise price, expiring on May 6, 2031, with a corrected expiration date noted for this option award.

NATIONAL HEALTHCARE CORP Senior VP & CIO Ben Anderson Flatt Sr reported compensation-related stock option activity. He exercised 4,000 options at an exercise price of $94.10 per share, receiving the same number of common shares.

The company withheld 2,739 common shares at $196.00 per share to cover the option exercise price and withholding tax obligations. Following these transactions, he directly beneficially owns about 22,636 common shares, and continues to hold stock options linked to 14,000 shares at $157.13 and 9,000 shares at $90.62 with expirations in 2031 and 2030, respectively.

NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. reported an open-market sale of 7,500 shares of common stock at $195.1421 per share. After this sale, he directly holds 205,760 common shares, indicating he retains a substantial equity position.

In addition to these shares, he holds multiple option awards covering 7,500 underlying shares each from grants dated 2022 through 2026, with exercise prices ranging from $55.75 to $171.42 and expirations between 2027 and 2031. No derivative options were exercised in this filing.

National Healthcare Corp CEO Stephen Fowler Flatt reported a small insider transaction involving a bona fide gift of 26 shares of Common Stock, leaving him with 66,987 shares held directly. The filing also updates his outstanding stock option awards.

He holds options over 20,000 shares of Common Stock at an exercise price of $157.13 expiring on February 23, 2031, 12,000 shares at $90.62 expiring on February 28, 2030, 5,000 shares at $94.10 expiring on March 5, 2029, and 4,294 shares at $53.94 expiring on March 8, 2028, all held directly.

National Healthcare Corp senior vice president sells shares and reports option holdings. Sr. VP of Operations Timothy J. Shelly reported an open-market sale of 1,853 shares of National Healthcare Corp common stock at an average price of $197.2176 per share, leaving him with 1,294 directly held shares.

He also reported several outstanding stock option awards on common stock, including options covering 14,000 shares at an exercise price of $157.13 expiring in 2031, 7,333 shares at $90.62 expiring in 2030, 5,333 shares at $94.10 expiring in 2029, and 2,400 shares at $53.94 expiring in 2028.

National Healthcare Corp CEO Stephen Fowler Flatt reported routine equity compensation activity. He exercised stock options to acquire a total of 6,000 shares of common stock at exercise prices of $90.62 and $94.10 per share. The company withheld 4,492 shares to pay the option exercise price and related tax obligations, a non‑market transaction. Following these transactions, Flatt beneficially owns 67,013 shares of common stock directly. He also retains unexercised options over 20,000 shares at an exercise price of $157.13 and options over 4,294 shares at $53.94, with expirations extending to 2031.

National Healthcare Corp SVP and CFO Brian F. Kidd exercised stock options and settled related obligations in shares. He exercised derivative securities covering 4,500 shares of common stock through option exercises and had 3,134 shares of common stock withheld by the company to pay the exercise price and tax withholding obligations. These transactions are compensation-related and were granted under the 2020 Omnibus Equity Incentive Plan. Kidd also retains unexercised options linked to 14,000 and 4,147 underlying common shares at exercise prices of $157.13 and $53.94 per share, respectively.

NATIONAL HEALTHCARE CORP director Sandra Y. Trail exercised stock options and increased her direct share holdings. On May 6, 2026, she exercised options to acquire 3,140 shares of common stock at an exercise price of $55.75 per share, bringing her direct ownership to 10,640 shares.

Trail continues to hold multiple option grants. These include a 2023 grant with 4,360 options remaining, plus 2024, 2025, and 2026 grants, each tied to 7,500 underlying shares with exercise prices between $94.66 and $171.42 and expirations from 2029 through 2031. The options were granted under the company’s 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).

National Healthcare Corp director William A. Adams received a grant of options to purchase 7,500 shares of common stock. The options have an exercise price of $171.42 per share, matching the closing price on May 7, 2026, and are scheduled to expire on May 6, 2030. This Form 4/A corrects a previous filing that had mistakenly reported the option price as $0.00, while the number of options and underlying shares remains 7,500.

NATIONAL HEALTHCARE CORP director Sandra Y. Trail reported a compensation-related award of stock options. She received an option to purchase 7,500 shares of common stock at an exercise price of $171.42 per share, granted under the 2020 Omnibus Equity Incentive Plan on May 7, 2026.

The option becomes exercisable on May 7, 2027 and expires on May 6, 2031. Following this filing, Trail holds 7,500 shares of common stock directly and has several prior option grants outstanding with exercise prices of $94.66, $96.03, and $55.75 per share, each covering 7,500 underlying shares. The company notes the grant and its potential exercise are exempt from Section 16(b) under Rule 16b-3(d).

NATIONAL HEALTHCARE CORP director James Paul Abernathy reported an equity award and updated holdings. He received an option to purchase 7,500 shares of common stock at an exercise price of $171.42 per share, expiring on May 6, 2031. The options were granted under the 2020 Omnibus Equity Incentive Plan and are described as exempt from Section 16(b) under Rule 16b-3(d).

Following the reported entries, he directly holds 43,302 shares of common stock. He also holds previously granted options covering 7,500 shares at $94.66, 7,500 shares at $96.03, and 4,360 shares at $55.75, providing additional potential future share exposure if exercised.

National Healthcare Corp director William A. Adams received a grant of options on 7,500 shares of common stock. The options were granted on May 7, 2026 under the company’s 2020 Omnibus Equity Incentive Plan with a stated exercise price of $0.00 per share and expire on May 6, 2030. Following this award, Adams holds options covering 7,500 shares directly as reported in this filing. The grant and potential exercise are described as exempt from Section 16(b) under Rule 16b-3(d), indicating this is a routine equity-based compensation award for a board member.

National Healthcare Corp director David R. Gifford received a new stock option grant. He was granted options to purchase 7,500 shares of NHC common stock at an exercise price of $171.42 per share. The options were granted under the 2020 Omnibus Equity Incentive Plan and are scheduled to expire on May 6, 2030. The grant is reported as a compensation-related award and is exempt from Section 16(b) under Rule 16b-3(d).

National Healthcare Corp director Lisa Piercey received a grant of stock options as compensation. On May 7, 2026, she was awarded options to purchase 7,500 shares of common stock at an exercise price of $171.42 per share, expiring on May 6, 2030. The options were granted under the company’s 2020 Omnibus Equity Incentive Plan, with no cash paid at grant, and leave her holding 7,500 options following the transaction.

National Healthcare Corp director Robert G. Adams reported a new stock option grant. He received options covering 7,500 shares of common stock at an exercise price of $171.42 per share, expiring on May 6, 2031.

The options were granted on May 7, 2026 under the company’s 2020 Omnibus Equity Incentive Plan, with no cash paid for the grant. The filing also lists existing option awards from 2022–2025 and indirect holdings of common stock in a trust and a partnership, but no open‑market share purchases or sales.

NATIONAL HEALTHCARE CORP director Emil E. Hassan received a new stock option grant as part of equity compensation. On May 7, 2026, he was granted options to purchase 7,500 shares of common stock at an exercise price of $171.42, vesting beginning May 7, 2027 and expiring May 6, 2031, under the 2020 Omnibus Equity Incentive Plan. Following this grant, he directly holds 73,095 shares of common stock and several prior option awards, each covering 7,500 shares at exercise prices of $94.66, $96.03, $55.75, and $69.19 with expirations from 2027 through 2030.

National Healthcare Corp director Richard F. LaRoche Jr reported updated holdings and a new stock option grant. He now directly holds 213,260 shares of common stock in his or his wife's name. On May 7, 2026, he received an option to purchase 7,500 shares of common stock at an exercise price of $171.42 per share.

The new 2026 option grant, issued under the 2020 Omnibus Equity Incentive Plan, becomes exercisable on May 7, 2027 and expires on May 6, 2031. LaRoche also continues to hold prior option awards from 2022, 2023, 2024 and 2025, each covering 7,500 underlying shares at exercise prices ranging from $55.75 to $96.03 per share.

NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. exercised stock options to acquire 7,500 shares of common stock on 2026-05-05 at an exercise price of $71.64 per share. After this derivative exercise, he directly holds 213,260 common shares.

He also retains four additional option grants under the company’s equity plans, each for 7,500 underlying shares, with exercise prices between $55.75 and $96.03 and expiration dates from 2027-05-04 through 2030-05-07, indicating a continuing equity stake through unexercised options.

National Healthcare Corp. director Emil E. Hassan reported an option exercise that increased his direct common stock holdings. On April 30, 2026, he exercised an option for 7,500 shares of common stock at an exercise price of $71.64 per share, moving those shares into direct ownership so that he now holds 73,095 shares of common stock directly.

The exercised option was the 2021 grant, which covered 7,500 underlying shares at $71.64; that option position is now fully used with zero options remaining from that grant. He also continues to hold four other option grants under the company’s equity plans, each covering 7,500 underlying shares with exercise prices of $94.66, $96.03, $55.75, and $69.19, expiring between 2027 and 2030. A footnote states these stock options were granted under the 2020 Omnibus Equity Incentive Plan and that the grant and exercise are exempt from Section 16(b) under Rule 16b-3(d).

NATIONAL HEALTHCARE CORP senior vice president of patient services Vicki L. Dodson exercised stock options and adjusted her equity holdings. On the reported date, she exercised options to acquire 4,000 shares of common stock at $94.10 per share.

The company withheld 2,853 shares at a value of $173.63 per share to cover the option exercise price and related tax obligations, a non‑market, tax-withholding disposition. Following these transactions, she directly owns about 18,412.5455 shares of common stock and retains stock options over 14,000 shares at $157.13 and 9,000 shares at $90.62, expiring in 2031 and 2030, respectively.

National Healthcare Corp Senior VP & CIO Ben Anderson Flatt Sr filed an amended insider report to correct a prior disclosure about shares withheld for taxes and exercise costs. The company withheld 2,109 shares of common stock at $176.81 per share to cover these obligations.

After this tax-withholding disposition, he directly holds 21,175.0547 shares of common stock. He also retains option awards covering 31,000 underlying shares at exercise prices of $94.10, $90.62, and $157.13, with expirations between 2029 and 2031.

National Healthcare Corp Senior VP & CIO Ben Anderson Flatt Sr reported a compensation-related stock option exercise. He exercised options for 3,734 shares of common stock at an exercise price of $53.94 per share, originally granted under the 2020 Omnibus Equity Incentive Plan.

To cover the exercise price and related tax withholding obligations, the company withheld 1,909 shares of common stock valued at $176.81 per share, a non-market disposition. Following these transactions, he directly beneficially owns 21,375.0547 shares of National Healthcare common stock.

He also continues to hold stock options over additional common shares, including 8,000 underlying shares at an exercise price of $94.10 expiring in 2029, 9,000 underlying shares at $90.62 expiring in 2030, and 14,000 underlying shares at $157.13 expiring in 2031.

NATIONAL HEALTHCARE CORP senior vice president Vicki L. Dodson exercised stock options and increased her direct shareholdings. She exercised options for 3,734 shares of common stock at an exercise price of $53.94 per share. To cover the exercise price and related tax obligations, the company withheld 2,034 shares valued at $164.96 per share, a non-market tax-withholding disposition rather than an open-market sale. After these transactions, she directly owns 14,412.5455 shares of common stock. She also continues to hold stock options over 8,000 shares at $94.10 per share expiring on March 5, 2029, 9,000 shares at $90.62 per share expiring on February 24, 2030, and 14,000 shares at $157.13 per share expiring on February 23, 2031.

National Healthcare Corp CEO Stephen Fowler Flatt exercised stock options to acquire 1,853 shares of common stock at an exercise price of $53.94 per share. These options were originally granted on March 8, 2023 under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).

Following the transaction, Flatt directly holds 65,505 shares of common stock. He also retains stock options covering 10,000 shares at $94.10, 13,000 shares at $90.62, and 20,000 shares at $157.13, with expiration dates between 2029 and 2031.

National HealthCare Corp SVP and CFO Brian F. Kidd exercised stock options for 1,853 shares of common stock at an exercise price of $53.94 per share. The options were originally granted under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).

Following the transaction, Kidd directly holds 29,130 shares of common stock. He also continues to hold options over 8,000 shares at an exercise price of $94.10, 9,500 shares at $90.62, and 14,000 shares at $157.13, with expirations between 2029 and 2031.

National Healthcare Corp director James Paul Abernathy exercised stock options and increased his direct shareholdings. He exercised options covering 3,140 shares of common stock at an exercise price of $55.75 per share, receiving 3,140 common shares. Following the transaction, he directly owns 43,302 common shares.

The exercised options were part of a 2023 grant under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d). Abernathy still holds two additional option grants, each linked to 7,500 underlying common shares, with exercise prices of $96.03 and $94.66 per share and expirations in 2029 and 2030.

NATIONAL HEALTHCARE CORP Sr. VP of Patient Services Vicki L. Dodson reported option-related transactions in company stock. On March 4, 2026, she exercised 4,500 stock options granted under the 2020 Omnibus Equity Incentive Plan, receiving 4,500 common shares at an exercise price of $0.00 per share and a corresponding entry at $90.62 per share for the acquired stock.

In a separate transaction coded "F," 3,159 shares of common stock were withheld by the company to cover the exercise price and tax-withholding obligations, rather than sold on the open market. Following these transactions, she beneficially owns 12,712.5455 shares of NATIONAL HEALTHCARE CORP common stock directly, and continues to hold multiple option awards with remaining exercisable balances.

National HealthCare Corp senior VP & CIO Ben Anderson Sr reported option exercises and related share withholdings. On March 4, 2026 he exercised multiple “Option to Purchase Common Stock” grants under the 2020 Omnibus Equity Incentive Plan into common shares. The company then withheld a portion of common stock to cover the exercise price and tax obligations, as noted in the footnotes. Following these transactions, he beneficially owned a total of 19,550.0547 shares of National HealthCare Corp common stock.

NATIONAL HEALTHCARE CORP Senior VP & General Counsel Josh A. McCreary reported option-related transactions in company stock. On March 4, 2026, he exercised options for 4,500 shares of common stock at an exercise price of $90.62 per share.

To cover the exercise price and related tax withholding obligations, 3,202 shares of common stock were withheld by the company, classified as a tax-withholding disposition rather than an open-market sale. Following these transactions, McCreary directly beneficially owned 12,698 shares of NATIONAL HEALTHCARE CORP common stock.

National Healthcare Corp senior executive exercises stock options and settles taxes in shares

Timothy J. Shelly, Sr. VP Operations of National Healthcare Corp, exercised options to purchase 2,667 and 3,667 shares of common stock on March 4, 2026. These options were granted under the 2020 Omnibus Equity Incentive Plan, as noted in the footnotes.

In connection with these exercises, 4,481 shares of common stock were withheld by the company to pay the option exercise price and related tax obligations. After these transactions, Shelly held 3,147 shares of common stock directly, along with 2,400 and 14,000 options to purchase common stock.

National Healthcare Corp (NHC) senior vice president and CFO Brian F. Kidd reported option exercises and related share withholdings in company stock. On March 4, 2026, he exercised options for 2,000 shares of common stock at $53.94 per share and 4,000 shares at $90.62 per share under the 2020 Omnibus Equity Incentive Plan. The filing shows a tax-related disposition of 3,947 shares of common stock at $172.83 per share, with shares withheld by the company to pay the exercise price and withholding taxes. Following these transactions, Kidd beneficially owned 27,277 shares of common stock and held options to purchase 8,000 and 14,000 shares, all as direct ownership.

Dodson Vicki L reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp senior vice president Vicki L. Dodson received an equity award of 1,082 shares of common stock. The award was granted at no cash cost to her and increased her directly held common stock to 11,371.5455 shares.

The 1,082 shares are restricted stock that vest over three years. One-third is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029, encouraging longer-term alignment with the company.

Shelly Timothy J. reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp senior vice president of operations Timothy J. Shelly received an equity award of 1,294 shares of common stock on February 27, 2026. The award was granted at $0.00 per share, indicating a stock-based compensation grant rather than an open-market purchase.

The granted shares are restricted and follow a three-year vesting schedule. One-third of the award is scheduled to vest on January 1, 2027, another third on January 1, 2028, and the final third on January 1, 2029. The filing also lists existing stock options, showing post-transaction holdings of 2,400, 8,000, 11,000, and 14,000 options under various grants, all held directly.

National Healthcare Corp CEO Stephen Fowler Flatt reported several equity transactions involving company stock. He exercised options to acquire 5,000 shares of common stock on March 2, 2026, at an exercise price effectively recorded as $0.0000 per option, increasing his directly held common shares to 67,237.

As part of the same event, 3,585 shares of common stock were withheld by the company at a price of $171.1500 per share to cover tax obligations, reducing his direct holdings to 63,652 shares. The filing also shows updated direct holdings of multiple option grants under the 2020 Omnibus Equity Incentive Plan, with post-transaction option positions of 6,147, 10,000 and 20,000 options.

Flatt Stephen Fowler reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp CEO Stephen Fowler Flatt was granted 3,090 shares of common stock on February 27, 2026, as a stock award with no cash paid per share. The grant consists of restricted shares subject to a three-year vesting schedule.

The award vests in three equal installments of 33 1/3% on January 1 of 2027, 2028, and 2029. The Form 4 also reports several option-to-purchase-common-stock positions, with post-transaction holdings of 6,147, 10,000, 18,000, and 20,000 option shares held directly.

National Healthcare Corp reported that SVP and CFO Brian F. Kidd acquired 1,507 shares of common stock on a grant or award basis at $0.00 per share. Following this grant, his directly held common stock totals 25,224 shares.

The footnote explains these are restricted shares that vest over three years, with 33 1/3% vesting on 1/1/2027, another 33 1/3% on 1/1/2028, and the final 33 1/3% on 1/1/2029. The filing also lists existing options to purchase common stock held directly.

National Healthcare Corp reported that Senior VP & General Counsel Josh A. McCreary acquired 1,458 shares of common stock on a restricted basis. These restricted shares vest over three years, in equal 33 1/3% installments on January 1 of 2027, 2028, and 2029. Following this grant, he directly holds 11,400 common shares, along with multiple option awards to purchase common stock reported as existing holdings.

FLATT BEN ANDERSON SR reported acquisition or exercise transactions in this Form 4 filing.

National Healthcare Corp senior vice president and CIO Ben Anderson Flatt Sr. received a grant of 1,342 shares of common stock on February 27, 2026. These are restricted shares granted at $0.00 per share, increasing his directly held common stock to 15,459.0547 shares after the award.

The restricted shares vest over three years, with 33 1/3% vesting on January 1, 2027, another 33 1/3% on January 1, 2028, and the final 33 1/3% on January 1, 2029. The filing also reports option holdings to purchase common stock, with several option positions listed as directly owned holdings.

NATIONAL HEALTHCARE CORP reported that Senior VP & General Counsel Josh A. McCreary received a grant of stock options to purchase 14,000 shares of common stock on February 23, 2026, at an exercise price of $0.00 per share.

The options were granted under the 2020 Omnibus Equity Incentive Plan and will vest in three equal parts: one-third on February 23, 2027, one-third on February 23, 2028, and the final one-third on February 23, 2029. The grant is described as exempt from Section 16(b) under Rule 16b-3(d).